Acadia Pharmaceuticals (ACAD) Research & Development (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted Research & Development of $81.6 million for Q2 2026, up 6.1% on a QoQ basis from $76.9 million in Q1 2026, and up 4.62% year-over-year from $78.0 million in Q2 2025.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Research & Development (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals has reported Research & Development for 17 years, with the latest figure at $81.6 million in Q2 2026.
- On a quarterly basis, Research & Development rose 4.62% year-over-year to $81.6 million in Q2 2026; TTM through Jun 2026 was $331.0 million, a 2.3% increase from a year earlier, with the FY2025 full-year figure at $328.8 million, up 8.43% from the prior year.
- Research & Development was $81.6 million for Q2 2026 at Acadia Pharmaceuticals, up from $76.9 million in the prior quarter.
- The five-year high for Research & Development was $157.0 million in Q3 2023, with the low at $58.8 million in Q2 2023.
- Average Research & Development over 5 years is $83.5 million, with a median of $77.4 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2024: Research & Development jumped 126.17% in 2022, then sank 57.57% in 2024.
- Over 5 years, Research & Development stood at $75.7 million in 2022, then dropped by 11.88% to $66.7 million in 2023, then surged by 50.93% to $100.7 million in 2024, then decreased by 15.86% to $84.8 million in 2025, then decreased by 3.78% to $81.6 million in 2026.
- The last three Research & Development figures came in at $81.6 million (Q2 2026), $76.9 million (Q1 2026), and $84.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Acadia Pharmaceuticals | 4.38 Bn | 3.42 Bn | 279.64 Mn | 81.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 81.56 Mn |
| Mar 31, 2026 | 76.87 Mn |
| Dec 31, 2025 | 84.76 Mn |
| Sep 30, 2025 | 87.83 Mn |
| Jun 30, 2025 | 77.95 Mn |
| Mar 31, 2025 | 78.27 Mn |
| Dec 31, 2024 | 100.73 Mn |
| Sep 30, 2024 | 66.61 Mn |
| Jun 30, 2024 | 76.23 Mn |
| Mar 31, 2024 | 59.68 Mn |
| Dec 31, 2023 | 66.74 Mn |
| Sep 30, 2023 | 156.96 Mn |
| Jun 30, 2023 | 58.77 Mn |
| Mar 31, 2023 | 69.14 Mn |
| Dec 31, 2022 | 75.74 Mn |
| Sep 30, 2022 | 81.34 Mn |
| Jun 30, 2022 | 75.65 Mn |
| Mar 31, 2022 | 128.86 Mn |
| Dec 31, 2021 | 66.94 Mn |
| Sep 30, 2021 | 58.57 Mn |
API Access
Acadia Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();